Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS Extension Study in Kidney Transplant Recipients
NCT00241059Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Primary endpoints: Safety parameters and Graft function. Started Aug 2002; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00241059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241059.